Brief: Prophase Labs Announces Preliminary Positive Results For Dietary Supplement Equivir
Feb 14 (Reuters) - Prophase Labs Inc PRPH.O :
* PROPHASE LABS ANNOUNCES PRELIMINARY POSITIVE RESULTS FOR
DIETARY
SUPPLEMENT EQUIVIR
* COMMERCIALIZATION OF EQUIVIR ANTICIPATED AFTER SECOND
TRIAL IS
COMPLETED IN Q2, 2024
Source text for Eikon: ID:nGNXwwJSj
Further company coverage: PRPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prophase Labs
See all newsBrief: Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:29 PM